mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.1 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.1 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |